Medication info
Tezalon 40 mg (Telmisartan)

Tezalon 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Hyuons Co., Ltd.
Appearance
White oblong tablet
Packaging
30 tablets/box [(10 tablets/PTP packaging x 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201603950 · Approved 2016.06.27 · Insurance code 670401400

Summary

Main use
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dosage is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides additional blood pressure-lowering effects when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dosage is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Hyuons Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension, protecting blood vessels and the heart. Additionally, it is used in high-risk patients aged 55 and older with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, or with evidence of end-organ damage due to diabetes, to reduce the risk of myocardial infarction, stroke, and death caused by cardiovascular disease. In this way, it helps improve health by reducing the risk of cardiovascular disease.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dosage is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides additional blood pressure-lowering effects when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dosage is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used by those who are allergic to this medicine or its components, pregnant or breastfeeding women, patients with severe liver impairment or biliary obstruction, hereditary angioedema patients, and those with diabetes or severe kidney impairment. Elderly patients, those with hyperkalemia, liver impairment, heart valve disease, ischemic heart disease, gastrointestinal disease, renal vascular hypertension, and severe kidney impairment should use this medication with caution, and co-administration with other RAAS agents is not recommended. During treatment, various adverse reactions may occur, including infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, vision abnormalities, heart and vascular problems, breathing difficulties, liver dysfunction, skin rash, muscle pain, and kidney dysfunction, so immediate consultation with a doctor is required if symptoms arise. In particular, if blood pressure drops suddenly, dizziness or fainting may occur, so appropriate measures such as lying the patient down and administering saline if necessary should be taken. Patients with impaired kidney function should have regular checks of serum potassium and creatinine levels, and those with hypovolemia or sodium depletion should correct these prior to administration to avoid the risk of hypotension. This medication may increase blood pressure-lowering effects when taken with other antihypertensive drugs, so caution is advised, and there may be interactions with some medications requiring consultation with a doctor before co-administration. Women who are pregnant or breastfeeding should preferably avoid this medication, and those planning to become pregnant should also avoid use. It is not recommended for children under 18 years as safety and efficacy are not established. Elderly patients should be administered with caution due to the risk of complications such as strokes from excessive lowering of blood pressure. In case of overdose, symptoms may include hypotension, abnormal heart rates, dizziness, and kidney impairment, so immediate medical assistance should be sought, and care must be taken as the drug is not removed by dialysis. This medicine should be kept out of reach of children and the packaging should not be opened until just before use. When driving or operating machinery, caution should be taken due to the possibility of dizziness or fainting.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 108 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • hives
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • renal impairment
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased creatine kinase
  • decreased hemoglobin
  • weakness
  • hunger
  • cold sweats
  • tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • blood pressure drop
  • fever
  • pneumonia
  • myalgia
  • increased creatine kinase
  • elevated serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a sealed container. Additionally, it should be kept at a temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

White oblong tablet

Package unit

30 tablets/box [(10 tablets/PTP packaging x 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.